Literature DB >> 1954077

Plasma metronidazole concentrations after single and repeated vaginal pessary administration.

I G Salas-Herrera1, M Lawson, A Johnston, P Turner, D M Gott, M J Dennis.   

Abstract

Metronidazole concentrations in plasma were measured by h.p.l.c. in 12 healthy female volunteers after single and repeated vaginal administration of 500 mg metronidazole pessaries. The area under the plasma concentration-time curve (AUC(0,12 h) was 8.4 +/- 3.9 micrograms ml-1 h (mean +/- s.d.) on day 1 and 20.6 +/- 7.1 micrograms ml-1 h (mean +/- s.d.) on day 5. The peak plasma drug concentration on day 1 was 1.2 +/- 0.6 micrograms ml-1 (mean +/- s.d.) and on day 5 it was 2.0 +/- 0.7 micrograms ml-1 (mean +/- s.d.). The plasma concentration of metronidazole at steady state was above the minimum inhibitory concentration (MIC) for anaerobic Streptococci and Clostridium tetani. These results demonstrate much lower systemic exposure than after oral administration.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1954077      PMCID: PMC1368641          DOI: 10.1111/j.1365-2125.1991.tb03962.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  15 in total

1.  An investigation of the comparative liposolubilities of beta-adrenoceptor blocking agents.

Authors:  P B Woods; M L Robinson
Journal:  J Pharm Pharmacol       Date:  1981-03       Impact factor: 3.765

Review 2.  Clinical pharmacokinetics of metronidazole.

Authors:  E D Ralph
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

Review 3.  Absorption from the vagina.

Authors:  D P Benziger; J Edelson
Journal:  Drug Metab Rev       Date:  1983       Impact factor: 4.518

4.  STRIPE: an interactive computer program for the analysis of drug pharmacokinetics.

Authors:  A Johnston; R C Woollard
Journal:  J Pharmacol Methods       Date:  1983-05

5.  Comparative pharmacokinetics of metronidazole and tinidazole as influenced by administration route.

Authors:  J Mattila; P T Männistö; R Mäntylä; S Nykänen; U Lamminsivu
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

6.  Determination of metronidazole and its two major metabolites in biological fluids by high pressure liquid chromatography.

Authors:  A Gulaid; G W Houghton; O R Lewellen; J Smith; P S Thorne
Journal:  Br J Clin Pharmacol       Date:  1978-11       Impact factor: 4.335

7.  A rapid and specific semi-micro method involving high-pressure liquid chromatography for the assay of metronidazole in plasma, saliva, serum, urine and whole blood.

Authors:  C M Kaye; M G Sankey; L A Thomas
Journal:  Br J Clin Pharmacol       Date:  1980-05       Impact factor: 4.335

8.  Trichomonal vaginitis: epidemiology and therapy.

Authors:  W F Peterson; F W Hansen; J E Stauch; C D Ryder
Journal:  Am J Obstet Gynecol       Date:  1967-02-15       Impact factor: 8.661

9.  Concentration of metronidazole in cervical mucus and serum after single and repeated oral doses.

Authors:  I G Salas-Herrera; R M Pearson; A Johnston; P Turner
Journal:  J Antimicrob Chemother       Date:  1991-08       Impact factor: 5.790

10.  Disposition kinetics of metronidazole in children.

Authors:  I Amon; K Amon; H Scharp; G Franke; F Nagel
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.